Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#761 most reported symptom for this vaccine
Upper respiratory tract congestion has been reported 17 times in association with Hib (Pedvaxhib) vaccination in VAERS. This represents 0.0% of all 60,298 reports for this vaccine.
Among these reports, 2 mentioned death (11.76%) and 3 involved hospitalization (17.6%).
Upper respiratory tract congestion is the #761 most frequently reported symptom for Hib (Pedvaxhib) out of 2013 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 17 reports of Upper respiratory tract congestion after Hib (Pedvaxhib) vaccination may seem alarming, but context is critical.
The 11.76% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.